Gritstone bio, Inc. Common Stock

Go to Gritstone bio, Inc. Common Stock Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$86.5 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patient...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Gritstone bio (GRTS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Related tickers: GRTS.

Read Full Article

Gritstone bio's GRANITE program shows promise in treating metastatic microsatellite stable colorectal cancer. Read why GRTS stock is a Buy.

Related tickers: GRTS.

Read Full Article
Trending Tickers
DATS

XNAS

$1.24
(%)
LASE

XNAS

$2.10
(%)
NYCB

XNYS

$2.97
(%)
PACW

XNAS

$7.54
(%)
MLGO

XNAS

$0.00
(%)